Phase 3 Muscular Dystrophy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a condition called myotonic dystrophy type 1 (DM1), confirmed by a genetic test showing a specific genetic repeat number greater than 100 (past test results from clinical testing are acceptable).
• People who are able to walk 10 metres and stand up from a chair and sit back down 5 times in a row on their own (basic ankle supports or insoles are allowed).
• People whose body weight relative to their height (BMI) is below 35 kg/m².

Who may not be able to join:

• People who have been diagnosed with the congenital (present-from-birth) form of DM1.
• People who have had a major surgical procedure within the 12 weeks before the start of the screening period, as judged by the trial investigator (having an implanted pacemaker or defibrillator is an exception to this).
• People who have recently used certain diabetes or weight-management medications — including semaglutide, dulaglutide, liraglutide, exenatide, or tirzepatide — within a specific timeframe before screening assessments (confirm exact timeframe with trial site).

Important: Other eligibility criteria not listed here may also apply. Always verify eligibility with the trial site directly before applying.